Dr Reddys Laboratories Share Price Today - Live Blog for August 14, 2025

With a -0.24% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,258.20. The stock is currently trading at a PE of 18.4000, while the industry PE is 33.7711, prompting investors to assess its value proposition.

With a -0.22% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,259.30. The stock is currently trading at a PE of 18.4000, while the industry PE is 33.7711, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd experienced a substantial 0.12% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,261.80, making it an appealing option for investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.20% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,260.20 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Demonstrating a commendable 0.04% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,257.00. In terms of valuation, the stock maintains a PE ratio of 18.4000, while the industry PE ratio stands at 33.7711.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.01%, with its current market value per share resting at ₹1,256.40. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's shares experienced a 0.01% uptick, and they are currently valued at ₹1,256.40, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.03%, reaching the current market price of ₹1,256.25. This development underscores the stock's growing popularity.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.06% gain, with the share price now at ₹1,255.65. Notably, the stock's PE ratio stands at 18.4000, and its Return on Equity (ROE) is 16.8559%.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.06%, reaching the current market price of ₹1,255.65. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd plunged by -0.16%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,254.95, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd observed a -0.05% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,257.00. The stock has a PE ratio of 18.4000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock price surged by 0.17%, reaching the current market value of ₹1,257.40 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd shares saw a -0.39% decrease, reaching a current market price of ₹1,255.25. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.4000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a -0.13% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,260.20. The stock has a PE ratio of 18.4000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.02% downturn in its share price, and it's currently trading at ₹1,260.00. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -0.07% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,260.30. Investors should examine the factors driving this decline. The stock's PE ratio is 18.4000, whereas the industry PE ratio stands at 33.7711.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.37%, reaching the current market price of ₹1,261.55. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.30%, with its current market value per share resting at ₹1,256.85. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd share price has declined by -0.03%, and it's currently trading at ₹1,253.30. The stock maintains a PE of 18.4000, while the industry PE is 33.7711, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's share price has fallen by -0.03%, a situation worth noting. At present, the stock is trading at ₹1,253.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.4000, while the industry PE ratio is 33.7711.

Dr Reddys Laboratories Ltd's share price has fallen by -0.02%, a situation worth noting. At present, the stock is trading at ₹1,253.80. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.4000, while the industry PE ratio is 33.7711.

Dr Reddys Laboratories Ltd observed a -0.50% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,255.35. The stock has a PE ratio of 18.4000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.08%, signalling a challenging period. Currently trading at ₹1,261.70, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Dr Reddys Laboratories Ltd is facing a -0.02% decline and is currently trading at ₹1,262.70 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd's share price rallied by 0.49%, reaching the current market price of ₹1,261.20. This surge is indicative of the stock's recent positive performance.